|
1. Semenza GL. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem. 2007 Nov; 102(4): 840-7. doi:10.1002/jcb.21523 2. Egginton S. Invited review: activity-induced angiogenesis. Pflugers Arch. 2009 Mar; 457(5): 963-77. doi:10.1007/s00424-008-0563-9 3. Kamat A, Rajoria S, George A, Suriano R, Shanmugam A, Megwalu U, et al. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Arch Otolaryngol Head Neck Surg. 2011 Nov; 137(11): 1146-53. doi:10.1001/archoto.2011.194 4. Baharara J, Zafar-Balanezhad S, Nejad-Shahrokhabadi K, Hesami Z. The effects of different doses of atorvastatin on angiogenesis of chorioallantoic membrane of chick embryo Journal of Shahrekord University of Medical Sciences. 2012; 14(2): 82-9. [Article in persian] 5. Le Bitoux MA, Stamenkovic I. Tumor-host interactions: the role of inflammation. Histochem Cell Biol. 2008 Dec; 130(6): 1079-90. doi:10.1007/s00418-008-0527-3 6. Fam NP, Verma S, Kutryk M, Stewart DJ. Clinician guide to angiogenesis. Circulation. 2003 Nov; 108(21): 2613-8. doi:10.1161/01.CIR.0000102939.04279.75 7. Kermorvant-Duchemin E, Pinel AC, Lavalette S, Lenne D, Raoul W, Calippe B, et al. Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina. PLoS One. 2013 Nov; 8(11): e79545. doi:10.1371/journal.pone.0079545 8. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr; 362(6423): 841-4. doi:10.1038/362841a0 9. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr; 362(6423): 841-4. doi:10.1038/362841a0 10. Pandya NM, Dhalla NS, Santani DD. Angiogenesis-a new target for future therapy. Vascul Pharmacol. 2006 May; 44(5): 265-74. doi:10.1016/j.vph.2006.01.005 11. Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, et al. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer. 2010 May; 126(9): 2090-101. doi:10.1002/ijc.24886 12. Fang S, Wei J, Pentinmikko N, Leinonen H, Salven P. Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell. PLoS Biol. 2012; 10(10): e1001407. doi:10.1371/journal.pbio.1001407 13. Tayebe R, Baharara J. [A review on angiogenesis in tumor] Journal of Cell & Tissue. Spring 2014; 5(1): 89-100. [Article in Persian] 14. Kanellopoulou C, Monticelli S. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol. 2008 Apr; 18(2): 79-88. doi:10.1016/j.semcancer.2008.01.002 15. Kim M, Kasinski AL, Slack FJ. MicroRNA therapeutics in preclinical cancer models. Lancet Oncol. 2011 Apr; 12(4): 319-21. doi:10.1016/S1470-2045(11)70067-5 16. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr; 362(6423): 841-4. doi:10.1038/362841a0 17. Iyer RP, Patterson NL, Fields GB, Lindsey ML. The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol. 2012 Oct; 303(8): H919-30. doi:10.1152/ajpheart.00577.2012 18. Egeblad M1, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002 Mar; 2(3): 161-74. doi:10.1038/nrc745 19. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005 Apr-Jun; 9(2): 267-85. 20. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001; 7(1): 14-23. 21. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008 Nov; 14(21): 6735-41. doi:10.1158/1078-0432.CCR-07-4843 22. Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, et al. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer. 2009 Sep; 45(14): 2618-27. doi:10.1016/j.ejca.2009.07.007 23. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011 Oct; 44(5): 839-47. doi:10.1016/j.jbi.2011.05.002 24. Dweep H, Sticht C, Gretz N. In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions. Current Genomics. 2013; 14(2): 127-36. doi:10.2174/1389202911314020005 25. Caldas C, Brenton JD. Sizing up miRNAs as cancer genes. Nat Med. 2005 Jul; 11(7): 712-4. 26. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006 Jun; 130(7): 2113-29.
|
